FDA Approved: HYDROCORTISONE BUTYRATE — Supplemental Application (Oceanside Pharmaceuticals)

View source ↗

Summary

FDA approved a supplemental application for hydrocortisone butyrate from Oceanside Pharmaceuticals, expanding its regulatory status under NDA 018652.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Dermatitis

Drugs mentioned

• Hydrocortisone Butyrate (hydrocortisone butyrate)

Snippet

SUPPL AP for HYDROCORTISONE BUTYRATE (HYDROCORTISONE BUTYRATE)